Literature DB >> 2428973

Geographutoxin II, a novel peptide inhibitor of Na channels of skeletal muscles and autonomic nerves.

Y Ohizumi, S Minoshima, M Takahashi, A Kajiwara, H Nakamura, J Kobayashi.   

Abstract

Geographutoxin II (GTX II, 3 X 10(-9) to 10(-7) M) from a cone shell Conus geographus inhibited twitch responses of the isolated mouse diaphragm to direct stimulation in a dose-dependent manner. The contraction of the diaphragm induced by grayanotoxin I or veratridine was abolished by GTX II (3 X 10(-7) M), whereas the contractile response to KCI or caffeine was not affected. GTX II induced similar effects on isolated bullfrog sartorius muscles, but required higher concentrations (6 X 10(-7) to 3 X 10(-6) M). GTX II (greater than 10(-6) M) inhibited or abolished the action potential evoked in sartorius muscles markedly. In the isolated guinea pig vas deferens and ileum, GTX II caused a dose-dependent inhibition of the twitch responses to indirect nerve stimulation at concentrations of 3 X 10(-8) to 10(-6) M and 10(-7) to 10(-6) M, respectively. But the toxin had no effect on the dose contractile-response curves for norepinephrine, carbamylcholine or KCI in the vas deferens and for carbamylcholine or histamine in the ileum. GTX II (5 X 10(-8) to 10(-6) M) decreased norepinephrine release induced by veratridine from the vas deferens in a dose-dependent manner. These results suggest that GTX II blocks the voltage-sensitive Na channels in the cell membrane of skeletal muscles and autonomic nerves and these may play an important role in the mechanism of inhibitory effects of GTX II on contractile responses of these tissues to electrical stimulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428973

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands.

Authors:  Denis B Tikhonov; Boris S Zhorov
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

2.  Use of geographutoxin II (mu-conotoxin) for the study of neuromuscular transmission in mouse.

Authors:  S J Hong; C C Chang
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  The mechanism of the inotropic action of striatoxin, a novel polypeptide toxin from a marine snail, in isolated cardiac muscle.

Authors:  Y Ohizumi; M Kobayashi; A Muroyama; H Nakamura; J Kobayashi
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

4.  Differential binding of tetrodotoxin and its derivatives to voltage-sensitive sodium channel subtypes (Nav 1.1 to Nav 1.7).

Authors:  Tadaaki Tsukamoto; Yukie Chiba; Minoru Wakamori; Tomoshi Yamada; Shunsuke Tsunogae; Yuko Cho; Ryo Sakakibara; Takuya Imazu; Shouta Tokoro; Yoshiki Satake; Masaatsu Adachi; Toshio Nishikawa; Mari Yotsu-Yamashita; Keiichi Konoki
Journal:  Br J Pharmacol       Date:  2017-09-20       Impact factor: 8.739

5.  Conotoxin GIIIA: selective inhibition of 22Na influx via voltage-dependent Na channels in adrenal medullary cells.

Authors:  A Wada; Y Uezono; M Arita; Y Yanagawa; M Satake; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

6.  Extrapore residues of the S5-S6 loop of domain 2 of the voltage-gated skeletal muscle sodium channel (rSkM1) contribute to the mu-conotoxin GIIIA binding site.

Authors:  M Chahine; J Sirois; P Marcotte; L Chen; R G Kallen
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

7.  Postsynaptic nicotinic receptor desensitized by non-contractile Ca2+ mobilization via protein kinase-C activation at the mouse neuromuscular junction.

Authors:  I Kimura; K Dezaki; H Tsuneki; M Kimura
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Molecular dynamics study of binding of µ-conotoxin GIIIA to the voltage-gated sodium channel Na(v)1.4.

Authors:  Somayeh Mahdavi; Serdar Kuyucak
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.